BD

Registration form

Want to deliver care without the sting of surgery?

People with B3 lesions are often undergoing avoidable surgery.^1-5

Vacuum-assisted biopsy (VAB) and breast tissue markers Vacuum-assisted excision (VAE)

Vacuum-assisted excision (VAE): A minimally invasive alternative to avoid the sting of surgery

With VAE, you can deliver precision and accuracy in your diagnoses and excisions of suspicious lesions^6-10

What lesions are treatable with VAE?^3,6-10

Diagram showing types of lesions treatable with vacuum-assisted excision. This includes the following B3 lesions: atypical ductal hyperplasia, atypical lobular hyperplasia, flat epithelial atypia, intraductal papilloma, lobular carcinoma in situ, papillary lesion, and radial scar/complex sclerosing lesion. Benign lesions are also treatable with VAB, such as fibroadenomas.

ADH, atypical ductal hyperplasia; ALH, atypical lobular hyperplasia; FEA, flat epithelial atypia; IDP, intraductal papilloma; LCIS, lobular carcinoma in situ; PL, papillary lesion; RS/CSL, radial scar/complex sclerosing lesion.

VAE treatment demonstrates comparable efficacy to surgery and a high complete resection rate, ranging from 70 to 100% across these lesion types.^6-9

The differences between VAB and VAE

Watch Dr Nisha Sharma discuss the differences between vacuum-assisted biopsy (VAB) and vacuum-assisted excision (VAE).

Breast with small skin incision following vacuum-assisted excision.

How VAE can minimise the threat to your patients

VAE minimises the threat of complications and scarring, leading to better cosmetic outcomes vs. surgery.^7,11-13 It's a gentler first step for the diagnosis and excision of suspicious lesions and can spare your patients the prolonged recovery times and anxiety associated with surgery.^8,14

Embrace the innovation of VAE

Lead with VAE to give your patients optimised clinical outcomes and experiences, all while maintaining efficiency and accuracy.^10,14-16

Protect your team and healthcare system from the burden of avoidable surgery

Using VAE brings reliable results, leading to reduced diagnostic underestimation, overtreatment, and reliance on surgery, thereby streamlining your workflow and increasing efficiencies.^9,11,14

How does VAE create efficiencies?

Cost icon

Limits avoidable costs such as those associated with general anaesthesia.^10,12,14,17

Hospital icon

Reduces the burden of breast lesion excision on surgical theatre resources.^10,14,17

Lower icon

Two times lower costs than open surgery when it comes to the excision of benign breast masses and B3 lesions.¹⁸

Analysis revealed that VAE significantly reduced costs per patient, with an average saving of £1,510.75.*⁺¹⁷

*~1,794.08€. Based on economic model in the UK to evaluate costs in 398 patients.¹⁷
⁺VAE remained cost-effective even in extreme scenarios, where the highest VAE cost was compared with the lowest surgical cost.

Explore how VAE is carried out in practice

Patient with a breast fibroadenoma confirmed by core biopsy three years prior, receiving VAE due to increase in size from 11 mm to 23 mm.

The tools, support and partnership you need to enhance your care

By partnering with us, you can benefit from continual innovation and ensure your care stays at the forefront of breast cancer diagnosis and treatment.

It's all part of our commitment to provide the training and support you need to incorporate VAB and breast tissue markers into your clinical workstream with confidence.

The Breast Intervention Masterclass is the result of over a decade of partnership with Breast Interventional Radiologists.

Learn more about the benefits of VAE

Let's have a conversation